123 related articles for article (PubMed ID: 33527588)
41. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
42. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
43. Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma.
Park YH; Jung JW; Lee BK; Lee S; Jeong SJ; Byun SS; Lee SE
Int J Urol; 2015 Feb; 22(2):153-7. PubMed ID: 25421791
[TBL] [Abstract][Full Text] [Related]
44. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Ko JJ; Xie W; Kroeger N; Lee JL; Rini BI; Knox JJ; Bjarnason GA; Srinivas S; Pal SK; Yuasa T; Smoragiewicz M; Donskov F; Kanesvaran R; Wood L; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Choueiri TK; Heng DY
Lancet Oncol; 2015 Mar; 16(3):293-300. PubMed ID: 25681967
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
[TBL] [Abstract][Full Text] [Related]
46. Impact of short warm ischemic time on longitudinal kidney function and survival rate after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease stage III: A multi-institutional propensity score-matched study.
Chung JS; Hong SK; Lee SC; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
Eur J Surg Oncol; 2021 Feb; 47(2):470-476. PubMed ID: 32631709
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic factors of patients with T3N0M0 renal cell carcinoma: a single-center retrospective study of 182 patients].
Peng D; Li XS; Zhang CJ; Yang KW; Tang Q; Zhang L; Yu XT; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):806-811. PubMed ID: 27752160
[TBL] [Abstract][Full Text] [Related]
48. Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survival.
Herout R; Graff J; Borkowetz A; Zastrow S; Leike S; Koch R; Draeger DL; Protzel C; Hakenberg OW; Wirth MP; Froehner M
Urol Oncol; 2018 Jan; 36(1):11.e1-11.e6. PubMed ID: 28927783
[TBL] [Abstract][Full Text] [Related]
49. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
Margulis V; Matin SF; Tannir N; Tamboli P; Swanson DA; Jonasch E; Wood CG
J Urol; 2008 Jul; 180(1):94-8. PubMed ID: 18485389
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
51. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis.
Choo MS; Jeong CW; Song C; Jeon HG; Seo SI; Hong SK; Byun SS; Chung JS; Hong SH; Hwang EC; Kim HH; Kwak C;
Clin Genitourin Cancer; 2017 Oct; 15(5):e819-e825. PubMed ID: 28549862
[TBL] [Abstract][Full Text] [Related]
53. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
[TBL] [Abstract][Full Text] [Related]
54. Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study.
Lee H; Jeong CW; Kwak C; Kim HH; Seo SI; Lee HM; Oh JJ; Lee SC; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2017 Dec; 15(6):e935-e941. PubMed ID: 28558989
[TBL] [Abstract][Full Text] [Related]
55. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
[TBL] [Abstract][Full Text] [Related]
56. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
Santoni M; Buti S; Conti A; Porta C; Procopio G; Sternberg CN; Bracarda S; Basso U; De Giorgi U; Rizzo M; Derosa L; Ortega C; Massari F; Milella M; Bersanelli M; Cerbone L; Muzzonigro G; Burattini L; Montironi R; Santini D; Cascinu S
Target Oncol; 2015 Dec; 10(4):517-22. PubMed ID: 25559290
[TBL] [Abstract][Full Text] [Related]
58. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
59. Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma: Comparison of Two Resection Techniques in a Multi-institutional Propensity Score-Matching Analysis.
Dong W; Lin T; Li F; Fang Y; Li K; Xu K; Jiang C; Bian L; Han J; Huang H; Liu H; Fan X; Zhang C; Lin X; Xie W; Yao Y; Ma Q; Chen Y; Huang Z; Zhang C; Chen W; Tan W; Huang J
Ann Surg Oncol; 2016 Apr; 23(4):1395-402. PubMed ID: 26727922
[TBL] [Abstract][Full Text] [Related]
60. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
